Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |